Health Alert: Most women with a common type of early-stage breast cancer can skip chemo, report finds

A highly anticipated new report showed that most patients who have an intermediate risk of a cancer recurrence — a group that numbers 65,000 women a year in the United States — can avoid chemotherapy and its often debilitating side effects. The findings — from the largest breast cancer treatment trial ever conducted — are sure to accelerate the decline in chemotherapy for the disease.

Democracy Dies in Darkness     Health Alert Jun 3, 8:12 AM     Most women with a common type of early-stage breast cancer can skip chemo, report finds A highly anticipated new report showed that most patients who have an intermediate risk of a cancer recurrence — a group that numbers 65,000 women a year in the United States — can avoid chemotherapy and its often debilitating side effects. The findings — from the largest breast cancer treatment trial ever conducted — are sure to accelerate the decline in chemotherapy for the disease. Read more » Advertisement You received this email because you signed up for news alerts from The Washington Post. Manage my newsletters and alerts | Unsubscribe Privacy Policy | Help ©2018 The Washington Post, 1301 K St NW, Washington DC 20071